(Q62110902)

English

Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma

clinical trial

In more languages

default for all languages

No label defined

No description defined

Statements

0 references

UARK 98-003, A Phase II Pilot Study of Anti-Angiogenesis Therapy Using Thalidomide in Patients With Multiple Myeloma (English)

0 references

medical condition

multiple myeloma

0 references

University of Arkansas

0 references

United States of America

0 references

February 1998

0 references

number of participants

250

0 references

research intervention

0 references

clinical trial phase

phase II clinical trial

0 references

University of Arkansas

0 references

research subject recruitment status

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110902&oldid=2149192268"